{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:58:10Z","timestamp":1769072290729,"version":"3.49.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.clim.2020.108456","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T18:41:27Z","timestamp":1588704087000},"page":"108456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Generation of high-affinity CMV-specific T cells for adoptive immunotherapy using IL-2, IL-15, and IL-21"],"prefix":"10.1016","volume":"217","author":[{"given":"Xiao-Hua","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingda","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenjiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Paraschoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clim.2020.108456_bb0005","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev. Med. Virol."},{"issue":"1","key":"10.1016\/j.clim.2020.108456_bb0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of CMV infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.clim.2020.108456_bb0015","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/cid\/ciu364","article-title":"Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation","volume":"59","author":"Ljungman","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.clim.2020.108456_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(15)00289-6","article-title":"Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study","volume":"3","author":"Green","year":"2016","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.clim.2020.108456_bb0025","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/631951","article-title":"Improving cytomegalovirus-specific T cell reconstitution after haploidentical stem cell transplantation","volume":"2014","author":"Luo","year":"2014","journal-title":"J Immunol Res"},{"issue":"7","key":"10.1016\/j.clim.2020.108456_bb0030","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.bbmt.2010.02.007","article-title":"Protective immunity transferred by infusion of cytomegalovirus-specific CD8+ T cells within donor grafts: its associations with cytomegalovirus reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation","volume":"16","author":"Luo","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"8","key":"10.1016\/j.clim.2020.108456_bb0035","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1182\/blood-2002-11-3472","article-title":"Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation","volume":"102","author":"Hakki","year":"2003","journal-title":"Blood."},{"issue":"12","key":"10.1016\/j.clim.2020.108456_bb0040","first-page":"3347","article-title":"Human cytomegalovirus infection and expression in human malignant glioma","volume":"62","author":"Cobbs","year":"2002","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.clim.2020.108456_bb0045","first-page":"159","article-title":"Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma","volume":"35","author":"Ghazi","year":"2012","journal-title":"J. Immunother. (Hagerstown, Md)"},{"issue":"9","key":"10.1016\/j.clim.2020.108456_bb0050","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/icb.2012.19","article-title":"Ex vivo functional analysis, expansion and adoptive transfer of cytomegalovirus-specific T-cells in patients with glioblastoma multiforme","volume":"90","author":"Crough","year":"2012","journal-title":"Immunol. Cell Biol."},{"issue":"10","key":"10.1016\/j.clim.2020.108456_bb0055","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMc1302145","article-title":"Survival in patients with glioblastoma receiving Valganciclovir","volume":"369","author":"S\u00f6derberg-Naucl\u00e9r","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.clim.2020.108456_bb0060","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1158\/0008-5472.CAN-14-0296","article-title":"Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastoma","volume":"74","author":"Schuessler","year":"2014","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.clim.2020.108456_bb0065","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1172\/JCI90599","article-title":"Immunotherapy for transplantation-associated viral infections","volume":"127","author":"Roddie","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"13","key":"10.1016\/j.clim.2020.108456_bb0070","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1158\/0008-5472.CAN-14-0296","article-title":"Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastoma","volume":"74","author":"Schuessler","year":"2014","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.clim.2020.108456_bb0075","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1084\/jem.20040613","article-title":"Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA\u2013peptide tetramers","volume":"202","author":"Cobbold","year":"2005","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.clim.2020.108456_bb0080","first-page":"651","article-title":"Sorting through subsets: which T cell populations mediate highly effective adoptive immunotherapy?","volume":"35","author":"Klebanoff","year":"2012","journal-title":"J. Immunother. (Hagerstown, Md)"},{"key":"10.1016\/j.clim.2020.108456_bb0085","series-title":"Seminars in Immunology","article-title":"Role of memory T cell subsets for adoptive immunotherapy","year":"2016"},{"issue":"2","key":"10.1016\/j.clim.2020.108456_bb0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/CJI.0000000000000111","article-title":"Expansion of tumor-reactive T cells from patients with pancreatic Cancer","volume":"39","author":"Meng","year":"2016","journal-title":"J. Immunother."},{"issue":"2","key":"10.1016\/j.clim.2020.108456_bb0095","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1252894","article-title":"Tumor-infiltrating lymphocytes (TILs) from patients with glioma","volume":"6","author":"Liu","year":"2017","journal-title":"OncoImmunology."},{"issue":"1\u20132","key":"10.1016\/j.clim.2020.108456_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-1759(98)00133-1","article-title":"Design and analysis of serial limiting dilution assays with small sample sizes","volume":"222","author":"Macken","year":"1999","journal-title":"J. Immunol. Methods"},{"issue":"6","key":"10.1016\/j.clim.2020.108456_bb0105","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ni1467","article-title":"Surface phenotype and antigenic specificity of human interleukin 17\u2013producing T helper memory cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.clim.2020.108456_bb0110","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.4049\/jimmunol.171.10.5116","article-title":"High avidity antigen-specific CTL identified by CD8-independent tetramer staining","volume":"171","author":"Choi","year":"2003","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.clim.2020.108456_bb0115","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.4049\/jimmunol.1203267","article-title":"Age-associated increase of low-avidity Cytomegalovirus-specific CD8+ T cells that re-express CD45RA","volume":"190","author":"Griffiths","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2020.108456_bb0120","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3389\/fimmu.2018.00760","article-title":"CMV-specific CD8+ T-cells with different TCR affinities segregate T-cell phenotypes and correlate with chronic GVHD in patients post-HSCT","volume":"9","author":"Poiret","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2020.108456_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00582","article-title":"Identifying individual T cell receptors of optimal avidity for tumor antigens","volume":"6","author":"Hebeisen","year":"2015","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2020.108456_bb0130","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1086\/377582","article-title":"Relevance of peptide avidity to the T cell receptor for cytomegalovirus-specific ex vivo CD8 T cell cytotoxicity","volume":"188","author":"Villacres","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.clim.2020.108456_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016245","article-title":"Resident memory T cells (T(RM)) are abundant in human lung: diversity, function, and antigen specificity","volume":"6","author":"Purwar","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clim.2020.108456_bb0140","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/eji.200636251","article-title":"Functional expression of chemokine receptor CCR6 on human effector memory CD8+ T cells","volume":"37","author":"Kondo","year":"2007","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2020.108456_bb0145","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1189\/jlb.1205725","article-title":"Functional and phenotypic analysis of human memory CD8+ T cells expressing CXCR3","volume":"80","author":"Kobayashi","year":"2006","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"10.1016\/j.clim.2020.108456_bb0150","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/intimm\/dxp019","article-title":"Human memory CCR4+ CD8+ T cell subset has the ability to produce multiple cytokines","volume":"21","author":"Kondo","year":"2009","journal-title":"Int. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2020.108456_bb2000","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1084\/jem.20040613","article-title":"Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA\u2013peptide tetramers","volume":"202","author":"Cobbold","year":"2005","journal-title":"J. Exp. Med."},{"issue":"18","key":"10.1016\/j.clim.2020.108456_bb3000","first-page":"3745","article-title":"Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation","volume":"121","author":"Blyth","year":"2013","journal-title":"Blood, J. Am. Soc Hematol."},{"issue":"7","key":"10.1016\/j.clim.2020.108456_bb5000","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/cid\/ciz368","article-title":"First-line Therapy With Donor-derived Human Cytomegalovirus (HCMV)\u2013specific T Cells Reduces Persistent HCMV Infection by Promoting Antiviral Immunity After Allogenic Stem Cell Transplantation","volume":"70","author":"Zhao","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.clim.2020.108456_bb0155","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/35105024","article-title":"T-cell regulation by CD28 and CTLA-4","volume":"1","author":"Alegre","year":"2001","journal-title":"Nat. Rev. Immunol."},{"issue":"25","key":"10.1016\/j.clim.2020.108456_bb0160","doi-asserted-by":"crossref","first-page":"9971","DOI":"10.1073\/pnas.1203543109","article-title":"Regulation of innate CD8+ T-cell activation mediated by cytokines","volume":"109","author":"Freeman","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.clim.2020.108456_bb0165","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2020.108456_bb0170","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrc2355","article-title":"Adoptive cell transfer: a clinical path to effective cancer immunotherapy","volume":"8","author":"Rosenberg","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.clim.2020.108456_bb0175","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1182\/blood-2005-06-2399","article-title":"IL-2 administration increases CD4+ CD25hi Foxp3+ regulatory T cells in cancer patients","volume":"107","author":"Ahmadzadeh","year":"2006","journal-title":"Blood."},{"issue":"6","key":"10.1016\/j.clim.2020.108456_bb0180","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1172\/JCI13296","article-title":"Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes","volume":"108","author":"Manjunath","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"24","key":"10.1016\/j.clim.2020.108456_bb0185","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1182\/blood-2011-10-386482","article-title":"Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer","volume":"119","author":"Yao","year":"2012","journal-title":"Blood."},{"issue":"21","key":"10.1016\/j.clim.2020.108456_bb0190","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1073\/pnas.200363097","article-title":"IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice","volume":"97","author":"Marks-Konczalik","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.clim.2020.108456_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-11-37","article-title":"IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells","volume":"11","author":"Santegoets","year":"2013","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.clim.2020.108456_bb0200","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.4049\/jimmunol.170.10.5018","article-title":"IL-15 promotes the survival of naive and memory phenotype CD8+ T cells","volume":"170","author":"Berard","year":"2003","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2020.108456_bb0205","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1172\/JCI27564","article-title":"IL-15 induces CD4+ effector memory T cell production and tissue emigration in nonhuman primates","volume":"116","author":"Picker","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.clim.2020.108456_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003362","article-title":"IL-21 restricts virus-driven Treg cell expansion in chronic LCMV infection","volume":"9","author":"Schmitz","year":"2013","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.clim.2020.108456_bb0215","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00262-010-0936-8","article-title":"IL-21-treated naive CD45RA+ CD8+ T cells represent a reliable source for producing leukemia-reactive cytotoxic T lymphocytes with high proliferative potential and early differentiation phenotype","volume":"60","author":"Albrecht","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"issue":"3","key":"10.1016\/j.clim.2020.108456_bb0220","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jcyt.2017.11.010","article-title":"Human papilloma virus\u2013specific T cells can be generated from na\u00efve T cells for use as an immunotherapeutic strategy for immunocompromised patients","volume":"20","author":"McCormack","year":"2018","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.clim.2020.108456_bb0225","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.4049\/jimmunol.175.4.2261","article-title":"IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response","volume":"175","author":"Li","year":"2005","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2020.108456_bb0235","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.4049\/jimmunol.179.6.3596","article-title":"IL-21 induces apoptosis of antigen-specific CD8+ T lymphocytes","volume":"179","author":"Barker","year":"2007","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2020.108456_bb0240","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.20041057","article-title":"Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function","volume":"201","author":"Zeng","year":"2005","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.clim.2020.108456_bb0245","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.4049\/jimmunol.169.10.5838","article-title":"Proliferation requirements of cytomegalovirus-specific, effector-type human CD8+ T cells","volume":"169","author":"van Leeuwen","year":"2002","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.clim.2020.108456_bb0250","first-page":"3877","article-title":"Interleukin 15 promotes antigen-independent in vitro expansion and long-term survival of anti-tumor cytotoxic T lymphocytes","volume":"8","author":"Lu","year":"2002","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.clim.2020.108456_bb0255","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrd4296","article-title":"Interleukin-21: a double-edged sword with therapeutic potential","volume":"13","author":"Spolski","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.clim.2020.108456_bb0260","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.4049\/jimmunol.1001221","article-title":"Exposure to IL-15 and IL-21 enables autoreactive CD8 T cells to respond to weak antigens and cause disease in a mouse model of autoimmune diabetes","volume":"186","author":"Ramanathan","year":"2011","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.clim.2020.108456_bb0265","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1172\/JCI42758","article-title":"Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation","volume":"120","author":"Hertoghs","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.clim.2020.108456_bb0270","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4049\/jimmunol.177.1.450","article-title":"Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection","volume":"177","author":"Munks","year":"2006","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2020.108456_bb0275","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.immuni.2008.07.017","article-title":"Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells","volume":"29","author":"Snyder","year":"2008","journal-title":"Immunity."},{"issue":"3","key":"10.1016\/j.clim.2020.108456_bb0280","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/imm.12991","article-title":"The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer","volume":"155","author":"Luo","year":"2018","journal-title":"Immunology."},{"issue":"4","key":"10.1016\/j.clim.2020.108456_bb0285","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1084\/jem.189.4.701","article-title":"T cell affinity maturation by selective expansion during infection","volume":"189","author":"Busch","year":"1999","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.clim.2020.108456_bb0290","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1084\/jem.20020369","article-title":"Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells","volume":"195","author":"Becker","year":"2002","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.clim.2020.108456_bb0295","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nri778","article-title":"Effector and memory T-cell differentiation: implications for vaccine development","volume":"2","author":"Kaech","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2020.108456_bb0300","doi-asserted-by":"crossref","first-page":"748","DOI":"10.4049\/jimmunol.179.2.748","article-title":"Cutting edge: CD8+ T cell clones possess the potential to differentiate into both high-and low-avidity effector cells","volume":"179","author":"Kroger","year":"2007","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2020.108456_bb0305","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.4049\/jimmunol.175.4.2261","article-title":"IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response","volume":"175","author":"Li","year":"2005","journal-title":"J. Immunol."},{"issue":"42","key":"10.1016\/j.clim.2020.108456_bb0310","doi-asserted-by":"crossref","first-page":"15154","DOI":"10.1073\/pnas.0406649101","article-title":"IL-15\/IL-15R\u03b1-mediated avidity maturation of memory CD8+ T cells","volume":"101","author":"Oh","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"35","key":"10.1016\/j.clim.2020.108456_bb0315","doi-asserted-by":"crossref","first-page":"12643","DOI":"10.1073\/pnas.0806877105","article-title":"Overcoming obstacles to the effective immunotherapy of human cancer","volume":"105","author":"Rosenberg","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.clim.2020.108456_bb0320","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1128\/JVI.01937-06","article-title":"CXCR3-dependent recruitment of antigen-specific T lymphocytes to the liver during murine cytomegalovirus infection","volume":"81","author":"Hokeness","year":"2007","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.clim.2020.108456_bb0325","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/leu.2013.66","article-title":"Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant","volume":"27","author":"Weber","year":"2013","journal-title":"Leukemia."},{"issue":"8","key":"10.1016\/j.clim.2020.108456_bb0330","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/mt.2012.130","article-title":"Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections","volume":"20","author":"Gerdemann","year":"2012","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.clim.2020.108456_bb0335","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1182\/blood-2011-09-381574","article-title":"Human virus-specific effector-type T cells accumulate in blood but not in lymph nodes","volume":"119","author":"Remmerswaal","year":"2012","journal-title":"Blood."},{"issue":"11","key":"10.1016\/j.clim.2020.108456_bb0340","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.4049\/jimmunol.168.11.5387","article-title":"Cutting edge: competition for APC by CTLs of different specificities is not functionally important during induction of antiviral responses","volume":"168","author":"Probst","year":"2002","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2020.108456_bb0345","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0952-7915(02)00009-2","article-title":"Epitope dominance, competition and T cell affinity maturation","volume":"15","author":"Kedl","year":"2003","journal-title":"Curr. Opin. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661619305091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661619305091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:00:42Z","timestamp":1761494442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661619305091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":71,"alternative-id":["S1521661619305091"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2020.108456","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of high-affinity CMV-specific T cells for adoptive immunotherapy using IL-2, IL-15, and IL-21","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2020.108456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108456"}}